Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

Recombinant antibody microarrays--a viable option?

Christer Wingren¹, Johan Ingvarsson, Malin Lindstedt

¹Department of Immunotechnology, Lund University, SE-220 07 Lund, Sweden.

Nature Biotechnology

|March 1, 2003

Summary

No abstract available in PubMed .

Related Experiment Videos

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Paucity of type 2 cytokines and atypical IL-5 receptor alpha patterns during established eosinophilic inflammation in seasonal allergic rhinitis.

Acta oto-laryngologica·2026

Same author

Artificial intelligence classification of spatial CD8 + T-cell distribution on computed tomography in oropharyngeal cancer.

Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology·2026

Same author

Cost savings and quality-of-life gains associated with the use of an AI-powered digital tool for self-management of chronic pain based on a multicenter cohort study.

Pain medicine (Malden, Mass.)·2026

Same author

Allergen-specific human IgE isolated through an allergen-agnostic pipeline-understanding immune response and allergen recognition.

Communications biology·2026

Same author

Tumour-infiltrating immune cells in tonsillar cancer: no tissue-level signs of inflammageing in the elderly.

Acta oto-laryngologica·2025

Same author

ATOR-4066, a Bispecific Antibody Targeting CD40 and CEACAM5, Induces Strong Myeloid and T Cell-Dependent Tumor Immunity and Synergizes with PD-1 Blockade.

Cancer immunology research·2025